Nuwellis (NASDAQ:NUWE) Issues Quarterly Earnings Results

Nuwellis (NASDAQ:NUWE) issued its quarterly earnings results on Monday. The company reported $1.74 EPS for the quarter, topping the consensus estimate of ($0.88) by $2.62, Zacks reports. The company had revenue of $2.37 million for the quarter, compared to the consensus estimate of $2.40 million. Nuwellis had a negative return on equity of 1,716.60% and a negative net margin of 169.54%. During the same period in the previous year, the business posted ($63.29) EPS.

Nuwellis Trading Up 1.0 %

NUWE stock traded up $0.02 during trading on Wednesday, hitting $1.95. The company had a trading volume of 715,058 shares, compared to its average volume of 947,576. The company has a fifty day moving average price of $1.52 and a two-hundred day moving average price of $3.92. The company has a market cap of $3.65 million, a P/E ratio of -0.02 and a beta of 0.36. Nuwellis has a fifty-two week low of $1.00 and a fifty-two week high of $31.15.

Analysts Set New Price Targets

Several research analysts have commented on the company. Roth Mkm reaffirmed a “buy” rating and issued a $17.00 price target on shares of Nuwellis in a research report on Tuesday, August 13th. Roth Capital upgraded Nuwellis to a “strong-buy” rating in a research report on Monday, July 29th.

About Nuwellis

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.